A wearable using AI to identify severe seizures and warn caregivers gains FDA approval - MedCity News

Embrace by Empatica is a smart watch for epilepsy management to identify convulsive seizures and send alerts to caregivers. Empatica, a Massachusetts Institute of Technology spinoff, received FDA clearance for a wristworn device that uses machine learning to alert people with epilepsy and their caregivers of a convulsive seizure and track their duration and frequency. Epilepsy affects a least 2.2 million people, according to data from the Epilepsy Foundation. Empatica's Emrace device assesses multiple indicators of a seizure, including electrodermal activity, a signal associated with fight or flight response that's used by stress researchers to quantify physiological changes related to sympathetic nervous system activity, the company statement noted. In a clinical trial of the device, 135 patients across multiple sites resided at epilepsy monitoring units with continuous monitoring with video-EEG and simultaneously wore an Empatica device.